Observational Study of Males With Creatine Transporter Deficiency

Clinical trial NCT02931682 · TERMINATED

Trial details

NCT number: NCT02931682
Sponsor: Ultragenyx Pharmaceutical Inc
Status: TERMINATED
Study type: OBSERVATIONAL

Creatine Deficiency, X-linked

Start date: 2016-12-01
Primary completion: 2022-10-24
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.